
Biologit
Developer of a scientific literature assessment platform designed to simplify the detection of adverse events from drug development to post-market. The company's platform monitors events in medical li...
Valuation
$10.8M
Latest known
Share Price
N/A
Total Raised
$3.2M
Last Round
N/A